Searched for
NOVO NORDISK CRO
Obesity drug maker Novo Nordisk ousts CEO as competition weighsNovo Nordisk CEO Lars Fruergaard Jorgensen will step down amidst growing concerns about the company's competitive position in the obesity d...- Goldman-backed Aragen eyes Rs 12,000 crore as pre-IPO dose; Novo Nordisk keenInvestors including Quadria Capital and Denmark-based pharmaceutical major Novo Nordisk are among those interested in a minority stake and ...
- Biocon posts 4.6% increase in net profit to Rs 89.65 croreBiotechnology firm Biocon's net profits for Q2 of FY13 was 89.65 crore, an increase of 4.6% when compared to the same period last year.
- Mumbai overtakes Bangalore, emerges as top biotech cityMumbai outpaced Bangalore, with a margin of about Rs 200 crore, to become India's top biotech city in terms of revenue.
- Market for biosimilars is very large in emerging markets: Kiran Mazumdar ShawIn an interview with ET Now, Kiran Mazumdar Shaw, Chairperson & Managing Director, Biocon, talks about the biosimilars market.
Load More